Stay updated on Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.
Latest updates to the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded Melanoma as a topic and a Related Topics link to MedlinePlus Genetics on the study page.SummaryDifference0.1%
- Check15 days agoChange DetectedExpanded the Locations section to include a comprehensive list of participating sites across multiple states and added a Revision: v3.3.3 tag. Removed the prior state-specific location blocks and the HHS Vulnerability Disclosure section.SummaryDifference2%
- Check23 days agoChange DetectedDeleted the study topic 'Melanoma' and the related topic 'MedlinePlus Genetics' from the page's related topics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check44 days agoChange DetectedThe page footer revision tag updated from v3.2.0 to v3.3.2. No study data or core functionality appears to be affected.SummaryDifference0.0%
- Check52 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page, and removed the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check59 days agoChange DetectedThe Melanoma topic and the MedlinePlus Genetics related topics were removed from the page's related topics section.SummaryDifference0.1%
Stay in the know with updates to Ipilimumab Plus Talimogene Laherparepvec Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Plus Talimogene Laherparepvec Clinical Trial page.